Healthcare >> CEO Interviews >> December 18, 2000
JORGEN BUUS LASSEN, DVM, is Co-founder of the Company and has been
President and CEO of NeuroSearch since May 1989. Dr Lassen has more than
30 years' experience within neuropharmacology and has authored or co-
authored more than 30 publications, including the first paper published
with respect to Paxil (paroxetine), an antidepressant. From 1980 to
1988, Dr Lassen served as Managing Director of Ferrosan's research and
development division. In this period, Dr Lassen was responsible for the
expansion of all pre-clinical and clinical activities requested by
health regulatory agencies. The most advanced of the development
substances studied was the antidepressant Paxil, being marketed
worldwide by SmithKline Beecham. In the same period, Dr Lassen
negotiated and concluded seven major research and development alliances.
Prior to that, Dr Lassen held a number of positions at Ferrosan and for
several years served as Director of Pharmacology. Dr Lassen serves as
Chairman of the Board of Zealand Pharmaceuticals A/S and NsGene and is a
member of the boards of M&E Biotech A/S, Bavarian Nordic Research
Institute A/S, NicOx and Scanbur A/S. Dr Lassen received his DVM from
the Royal School of Veterinary and Agriculture Science in Copenhagen. Profile
me an snapshot introduction to NeuroSearch to frame recent developments.
Dr. Lassen: We are a pharmaceutical R&D
